Mitomycin C, a widely used chemotherapeutic drug, has been proposed as a potential adjuvant for the control of scar tissue in surgical wounds because of its capacity to inhibit fibroblast proliferation. The current study used a combination of topical and injected mitomycin C to slow the healing process of surgical wounds in rats.
Methods:
An experimental model of surgical wounding at the dorsum of rats was used. A total of 43 animals were subdivided into 3 groups: Control, topical mitomycin C, and a combination of topical treatment and intradermal injections of the drug at 30 and 60 days after the initial topical treatment. After 3 months, the animals were painlessly sacrificed and the surgical scars were removed for microscopic analysis.
Results:
The group that received only topical mitomycin C presented milder inflammatory signs and consequently had a less intense healing process than the control group. The group treated with a combination of both topical and injected mitomycin C presented results comparable to those of the control group.
Conclusions:
The toxic characteristics of mitomycin C were most likely responsible for the greater tissue damage that occurred when it was used in the injected form, causing increased scar tissue formation. Mitomycin C slows the healing process of surgical wounds when used topically, but causes enhanced scar tissue formation when injected.
MiyamuraSShigenoNMatsuiMWakakiSUzuK. The biological studies on mitomycin I. Antibacterial activities of mitomycin derivatives. J Antibiot (Tokyo)1967;20:72–6.
2.
BradnerWT. Mitomycin C: A clinical update. Cancer Treat Rev2001;27:35–50.
3.
De BruijnEASleeboomHPvan HelsdingenPJROvan OosteromATTjadenURMaesRAA. Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times. Int J Cancer1992;51:359–64.
4.
HuDSiresBSTongDCRoyackGAOdaD. Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg2000;16:119–25.
5.
ManuskiattiWFitzpatrickRE. Treatment response of keloid and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol2002;138:1149–55.
6.
GraySDTritleNLiW. The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope2003;113:237–42.
7.
IngramsDRVolkMSBiesmanBSPankratovMMShapshaySM. Sinus surgery: Does mitomycin C reduce stenosis?. Laryngoscope1998;108:883–6.
8.
SpectorJEWerkhavenJASpectorNC. Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope1999;109:1125–9.
9.
GarrettCGSotoJRiddickJBillanteCRReinischL. Effect of mitomycin-C on vocal fold healing in a canine model. Ann Otol Rhinol Laryngol2001;110:25–30.
10.
RahbarRShapshaySMHealyGB. Mitomycin: Effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol2001;110:1–6.
11.
CoppitGPerkinsJMunarettoJNielsenRMcKinneyLUlnickK. The effects of mitomycin-C and stenting on airway wound healing after laryngotracheal reconstruction in a pig model. Int J Pediatr Otorhinolaryngol2000;53:125–35.
12.
SimpsonCBJamesJC. The efficacy of mitomycin-C in the treatment of laryngotracheal stenosis. Laryngoscope2006;116:1923–5.
13.
RohJLLeeYWParkCI. Can mitomycin C really prevent airway stenosis?. Laryngoscope2006;116:440–5.
14.
UbellMLEttemaSLToohillRJSimpsonCBMeratiAL. Mitomycin-c application in airway stenosis surgery: Analysis of safety and costs. Otolaryngol Head Neck Surg2006;134:403–6.
15.
JassirDBuchmanCAGomez-MarinO. Safety and efficacy of topical mitomycin C in myringotomy patency. Otolaryngol Head Neck Surg2001;124:368–73.
16.
EstremSABatraPS. Preventing myringotomy closure with topical mitomycin C in rats. Otolaryngol Head Neck Surg1999;120:794–8.
17.
O'ReillyRCGoldmanSAWidnerSACassSP. Creating a stable tympanic membrane perforation using mitomycin C. Otolaryngol Head Neck Surg2001;124:40–5.
18.
ChungJHCosenzaMJRahbarRMetsonRB. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: A randomized, controlled study. Otolaryngol Head Neck Surg2002;126:468–74.
19.
JonesLMGuilloryVLMairEA. Total nasopharyngeal stenosis: Treatment with laser excision, nasopharyngeal obturators, and topical mitomycin-c. Otolaryngol Head Neck Surg2005;133:795–8.
20.
KimSTGangIGChaHEHaJSChungYS. Effect of mitomycin C on the size of antrostomy after endoscopic sinus surgery. Ann Otol Rhinol Laryngol2006;115:673–8.
21.
ChanKOGervaisMTsaparasYGenowayKAManareyCJaverAR. Effectiveness of intraoperative mitomycin C in maintaining the patency of a frontal sinusotomy: A preliminary report of a double-blind randomized placebo-controlled trial. Am J Rhinol2006;20:295–9.
22.
YazawaYSuzukiMKitanoHKitajimaK. Intraoperative mitomycin C in endolymphatic sac surgery for Ménièrés disease: A pilot study. ORL J Otorhinolaryngol Relat Spec1999;61:188–94.
23.
CubukçuAAlponatAGönüllüNNOzkanSErçinC. An experimental study evaluating the effect of mitomycin C on the prevention of postoperative intraabdominal adhesions. J Surg Res2001;96:163–6.
24.
AydinEUckanSOzdemirBHUyarP. Mitomycin C effect on fibrous adhesions of rabbit temporomandibular joint. Otolaryngol Head Neck Surg2005;133:672–6.
25.
RibeiroFAQGuaraldoLBorgesJPZacchiFFSEckleyCA. Clinical and histological healing of surgical wounds treated with mitomycin C. Laryngoscope2004;114:148–52.
26.
FergusonBGraySDThibeaultS. Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins. Laryngoscope2005;115:110–5.
27.
PorterGTGadreSACalhounKH, The effects of intradermal and topical mitomycin C on wound healing. Otolaryngol Head Neck Surg2006;135:56–60.
28.
MoodyMWLangHSpiessACSmytheNLambertPRSchmiedtRA. Topical application of mitomycin C to the middle ear is ototoxic in the gerbil. Otol Neurotol2006;27:1186–92.
29.
RohJLKooBSYoonYHRhaKSParkCI. Effect of topical mitomycin C on the healing of surgical and laser wounds: A hint on clinical application. Otolaryngol Head Neck Surg2005;133:851–6.
30.
RohJLKimDHRhaKSSungMWKimKHParkCI. Benefits and risks of mitomycin use in the traumatized tracheal mucosa. Otolaryngol Head Neck Surg2007;136:459–63.
31.
HuemanEMSimpsonCB. Airway complications from topical mitomycin C. Otolaryngol Head Neck Surg2005;133:831–5.
32.
HartnickCJHartleyBELacyPD. Topical mitomycin application after laryngotracheal reconstruction: A randomized, double-blind, placebo-controlled trial. Arch Otolaryngol Head Neck Surg2001;127:1260–4.
33.
EliasharRGrossMMalyBSichelJY. Mitomycin does not prevent laryngotracheal repeat stenosis after endoscopic dilation surgery: An animal study. Laryngoscope2004;114:743–6.
